A double-blind, placebo-controlled, randomized 24-month study, assessing the effect of celecoxib (Celebrex) long term treatment on hip osteoarthritis (OA) progression OSCARE.
Phase of Trial: Phase III
Latest Information Update: 06 Dec 2018
At a glance
- Drugs Celecoxib (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Acronyms OSCARE
- Sponsors Pfizer
- 06 Dec 2018 Last checked against ClinicalTrials.gov record.
- 29 Aug 2006 Status change
- 18 Dec 2005 New trial record.